News
LONDON & NEW YORK--(BUSINESS WIRE)--ViroCell Biologics (“ViroCell” or the “Company”), a specialist viral vector Contract ... ALL is the most common cancer in childhood and, whilst 85% ...
There is a consistent need from researchers to manufacture a cGMP virus to support the advancement of gene therapies.
UCL leveraged ViroCell's expertise in lentiviral vector manufacturing for an innovative ... ALL is the most common cancer in childhood and, whilst 85% of patients can be cured with conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results